Valid

YY/T 1652-2019General technical requirements of quality control materials for in vitro diagnostic reagents (English PDF)

体外诊断试剂用质控物通用技术要求

Preview PDF

This is a limited preview

Buy now to download the full PDF (18 pages)

Need quotation for your management?

Get a formal quotation for YY/T 1652-2019 in 30 minutes.

Issued by

NMPA

Level / Type

Industry · Recommended

Issue date

May 31, 2019

Implementation date

June 1, 2020

Scope

YY/T 1652-2019 is the English-translated version of 体外诊断试剂用质控物通用技术要求.

YY/T 1652-2019 is the Chinese pharmaceutical industry standard that sets the general technical requirements for quality control materials used with in vitro diagnostic reagents, the samples a laboratory runs alongside patient specimens to check that an assay is still in control.

It gives the requirements, the test methods, the labels and instructions for use and the rules for packaging, transport and storage, with an informative appendix on the principles for assigning values to a control material, on matrix effects and on biosafety.

It applies to control materials intended for the quality control of the reagents they are matched to, and not to materials used for verifying correctness. Issued on 31 May 2019, it has applied since 1 June 2020.

Found what you need?

Document preview — YY/T 1652-2019

National Standard of the People's Republic of China

Issued by: National Medical Products Administration of the People's Republic of China

Contents

  • Foreword3
  • 1 Scope4
  • 2 Normative references4
  • 3 Terms and definitions5
  • 4 Requirements6
  • 5 Test methods8
  • 6 Labels and instructions for use15
  • 7 Packaging, transportation, and storage15
  • Appendix A (Informative) Study principles for control material valuing, matrix effect, and biosafety16
  • Bibliography18

1 Scope

This Standard specifies the requirements, test methods, labels and instructions for use, packaging, transportation, and storage of quality control materials for in vitro diagnostic reagents.

This Standard applies to quality control materials intended for the quality control of adapted reagents. This Standard does not apply to:

a) Quality control materials for correctness verification;

b) Quality control materials for external quality assessment;

c) Quality control materials for the detection of microorganisms, immunohistochemistry, molecular pathology, morphology, etc.;

d) Except for the above circumstances, if still inapplicable, the manufacturer must provide a reason.

2 Normative references

The following documents are indispensable for the application of this document.

For the dated references, only the editions with the dates indicated are applicable to this document. For the undated references, the latest edition (including all the amendments) are applicable to this document.

GB/T 191 Packaging - Pictorial Marking for Handling of Goods

GB/T 21415-2008 In vitro diagnostic medical devices - Measurement of quantities in biological samples - Metrological traceability of values assigned to calibrators and control materials

GB/T 29791.1-2013 In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 1: Terms, definitions and general requirements

GB/T 29791.2 In vitro diagnostic medical devices - Information supplied by

4 Requirements

4.1 Appearance

It shall comply with the manufacturer's stated requirements such as status, packaging, and identification.

4.2 Packing volumes

The packing volumes of liquid quality control material are not less than the volumes indicated.

4.3 Intended result

The control material is measured on the claimed detection system. The result shall be in accordance with the manufacturer's stated intended result.

4.4 Homogeneity

TAKE the control materials of a certain number (n>=10) of minimum package units of the same batch number. The result shall meet the manufacturer's stated homogeneity requirement.

4.5 Stability

4.5.1 Unsealing/redissolving stability

The manufacturer shall, in order of priority, select one of the following methods for verification:

a) It shall specify the stability period of the control material under the specified storage conditions after the first unsealing/redissolving. The difference between the detection result of control material at the end of the stability period and that of the newly-unsealed/redissolved control material is not significant.

b) It shall specify the stability period of the control material under the specified storage conditions after the first unsealing/redissolving. The relative deviation between the detection result of control material at the end of the stability period and that of the newly-unsealed/redissolved control material shall meet the manufacturer's stated range requirement.

c) It shall specify the stability period of the control material under the specified storage conditions after the first unsealing/redissolving. Detection is performed at the end of the stability period. The result shall be in accordance with the intended result claimed by the manufacturer.

a) The quality control material within the expiration date is detected according to the manufacturer's claimed thermal stability method. The quality control material at the end of the thermal stability period is simultaneously detected with the normally-stored quality control material.

The relative deviation of the detection result shall be within the range claimed by the manufacturer.

b) The quality control material within the expiration date is detected according to the manufacturer's claimed thermal stability method. The detection result at the end of the thermal stability period shall meet the claimed intended result.

Note 1: Numerical quality control materials such as those with acceptable intervals/values/measurement signal values are suitable for method a) or b).

Note 2: Non-numerical quality control materials such as those with negative/positive results only and no measurement signal values are suitable for method b).

Note 3: If the above methods are not applicable, the manufacturer must explain the reasons and provide applicable verification methods.

Note 4: Thermal stability cannot be used to derive product expiration date unless a derivation formula based on a large number of stability study data is used.

Note 5: According to the product characteristics, different test methods may be selected.

However, the selected method should be able to verify the product stability, to ensure that the product performance within the expiration date meets the standard requirements. See Appendix A for related study principles.

5 Test methods

5.1 Appearance

Visual inspection by normal vision. It shall meet the requirements of 4.1.

5.2 Packing volumes

USE a universal measuring tool to measure 3 times. Each measurement result shall meet the requirements of 4.2.

5.3 Intended result

The control material is measured on the claimed detection system. The measurement is repeated no less than 3 times. Each measurement result shall n1 - Number of measurements for newly-unsealed/redissolved quality control material; s1 - Standard deviation of the measurement of newly- unsealed/redissolved quality control material; n2 - Number of measurements for the quality control material at the end of unsealing/redissolving stability period; s2 - Standard deviation of the measurement of the quality control material at the end of unsealing/redissolving stability period.

If the t< critical value talpha(n1+n2-2) of the degree of freedom (n1+n2-2) of significance level alpha (usually alpha=0.05), there is no significant difference between the two average values.

Note: In order to ensure the accuracy of the average and standard deviation, both n1 and n2 are >=6.

b) It shall specify the stability period of the control material under the specified storage conditions after the first unsealing/redissolving. TAKE the newly-unsealed/redissolved quality control material and the control material at the end of the stability period to detect at the same time. The measurement is repeated 3 times. The average values of the detection results are recorded as X0 and X, respectively. According to the formula (17), calculate the relative deviation B of the result. The result shall meet the requirements of 4.5.1 b). Where: B - Relative deviation;

X - The average of the detection result at the end of the stability period;

X0 - The average of the initial detection result after unsealing/redissolving.

c) It shall specify the stability period of the control material under the specified storage conditions after the first unsealing/redissolving. TAKE the quality control material at the end of the stability period for detection. The detection is repeated 3 times. Each detection result shall comply with the requirements of 4.5.1 c).

Appendix A (Informative)

Study principles for control material valuing, matrix effect, and biosafety

A.1 Valuing of quality control materials

For valued control materials, the manufacturer shall assign values to the control materials and describe the materials and methods used, including but not limited to the following:

a) The detection system used (detection method and instrument);

b) Number of laboratories, number of tests per laboratory, number of repetitions, reagent batches, number of equipment, and duration of assessment;

c) The statistical analysis method used;

d) The results of each analyte level, including coefficient of variation, standard deviation, and confidence interval.

A.2 Matrix effect

Ideally, the composition of quality control material shall be as close as possible to the composition of the human sample, thereby minimizing the effects of the matrix and correctly reflecting the detection value of the sample. In actual development, in order to reduce consumption, it is more convenient and safer to make some changes to the matrix. For example, animal or synthetic matrices are used to protect the experimenter from infectious pathogens; preservatives, stabilizers, antibacterial agents, and clarifying agents are also added to increase the ease of use and stability of control material; production processes (such as lyophilization or inactivation) can significantly alter the physical, chemical, and biological properties of control material. Despite the benefits of various matrices and additives, the difference between these and human samples may result in the inability of the control material to fully reflect the detection performance of the human sample. Therefore, it is recommended that the manufacturer evaluate the matrix of the control material during the study process, add the analyte capable of covering the measurement range in parallel in the control material matrix and the human sample, and compare the results to determine deviations, precision differences, and stability differences, etc. of the control material matrix relative to the natural sample. If necessary, refer to the CLSI guidelines EP-14, EP-30 for assessment of matrix effect.

......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 18 pages — is available in the English PDF.

Referenced standards

Similar standards

How to Download YY/T 1652-2019

  1. 1

    Add to cart

    Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.

  2. 2

    Checkout

    Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).

  3. 3

    Fast delivery

    After payment you'll receive an email confirmation. The English PDF is sent to the same address, usually within minutes and at the latest within 1 business day.

  4. 4

    Invoice included

    A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.

Related Standards

English PDF
18 pages
Fast delivery
Invoice included
View Cart

Secure payment via Stripe

Payments accepted

VisaMastercardAmerican ExpressApple PayGoogle PayStripe

YY/T 1652-2019

$210.00